Position in ALKS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$8,474,765
+$1,727,864 QoQ
Shares Held
239,671
-0.6% QoQ
Ownership
0.144%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $407,067,928 across 27 Drug Manufacturers - Specialty & Generic names. ALKS ranks #6 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
1,493,813 | $196,794,922 | |
| 2 | ZTS |
Zoetis Inc.
|
1,034,115 | $122,242,733 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
72,715 | $43,118,539 | |
| 4 | VTRS |
Viatris Inc
|
1,108,006 | $14,969,159 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
391,587 | $11,794,600 | |
| 6 | ALKS |
Alkermes plc.
This page
|
239,671 | $8,474,765 | |
| 7 | BHC |
Bausch Health Companies Inc.
|
683,997 | $3,693,583 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
117,894 | $2,664,403 |
All Filings in ALKS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,474,765 | 239,671 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $6,746,901 | 241,133 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $53,310 | 1,777 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $49,466 | 1,729 | Shares | Defined | 2025-08-06 | |
| No filing history on record for this holder in this stock. | ||||||